跳至主要内容
临床试验/NCT02576522
NCT02576522已完成不适用

Tumor Bed Hypofractionated IMRT (VMAT-RA) After Surgical Resection for Patients With Single, Large (≥2.1 cm) Brain Metastases From Solid Tumor

Istituto Clinico Humanitas2 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2015年6月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
87
试验地点
2
主要终点
Local control rate

研究概览

简要总结

Investigators designed a study of a multimodality approach: surgery followed by hypofractionated intensity modulated radiation therapy (IMRT) using VMAT approach for patients with single, large brain metastases from solid primary tumor

详细描述

Investigators designed a study to recruit patients with single, large brain metastases from solid primary tumor for a multimodality approach: surgery followed by hypofractionated intensity modulated radiation therapy (IMRT) using VMAT approach. The potential advantage of this treatment is to improve local control and to reduce toxicity compared with WBRT or SRS after surgical resection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Karnosky performance status (KPS) ≥70
  • All Solid tumor (esclusion SCLC and Germinal tumors)
  • Controlled primary tumor
  • Controlled other metastatic site
  • Single metastatic lesion at diagnosis
  • Lesions ≥ 2.1 cm in maximum diameter (4 cm3), < 3 cm conditioning mass effect or neurological deficits or massive aedema, unknown primary tumor
  • Estimated survival ≥ 3 months.
  • Written informed consent

排除标准

  • Prior WBRT
  • Other primary cancer
  • Pregnant women

研究组 & 干预措施

brain metastatic patients

Experimental

Patients with single, large brain metastases from solid tumors

干预措施: brain metastatic patients (Radiation)

结局指标

主要结局

Local control rate

时间窗: 6 months

次要结局

  • Distant brain failure(6 months)
  • Overall survival, statistical(6 months)
  • Morbidity/mortality after surgery(1 month)
  • Radionecrosis after treatments(6 months)
  • Neuropsycological alterations after treatments, questionnaire(6 months)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michele Tedeschi

MD

Istituto Clinico Humanitas

研究点 (2)

Loading locations...

相似试验